cytarabine has been researched along with Hypoalbuminemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JY; Chang, EWY; Farid, M; Khoo, LP; Lim, ST; Poon, E; Somasundaram, N; Tang, TPL; Tao, M; Yang, VS; Yang, X | 1 |
| Boula, AM; Christoforidou, AV; Foudoulakis, AM; Mantadakis, E; Samonis, G; Xilouri, IM | 1 |
2 other study(ies) available for cytarabine and Hypoalbuminemia
| Article | Year |
|---|---|
Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Hypoalbuminemia; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Maintenance Chemotherapy; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Risk Factors; Rituximab; Singapore; Transplantation, Autologous | 2021 |
Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Fatal Outcome; Hepatic Veno-Occlusive Disease; Humans; Hypoalbuminemia; Leukemia, Myelomonocytic, Chronic; Male; Paresis; Renal Insufficiency; Thrombocytopenia; Vincristine | 2005 |